MEDIWOUND LTD
MDWDNASDAQ🏆 #2831 by market capUS Equity
$678.68▲ $11.20 (+1.65%)
Simulated price1h—
24h▲ 1.6%
7d—
14d—
30d—
1y—
🏦Market Cap
$188M
Small Cap
📈Revenue Growth (YoY)
-24.6%
Declining
📊Gross Margin
19.6%
Thin
💵FCF Margin
—
⚖️P/S Ratio
13.4x
Elevated
Otter Score
56
Weak
No chart data available for MDWD.
Trading Snapshot
- Day Range
- $672.73 – $689.37
- 52-Week Range
- $13.54 – $21.26
- Volume
- $2.87B
- Avg Volume
- $2.99B
- Shares Outstanding
- 12.8M
- Next Earnings
- Oct 15, 2026
Fundamentals Snapshot
- Annual Revenue
- $14M
- Last Q Revenue
- $3M
- P/E Ratio
- —
- P/S Ratio
- 13.4x
- EPS (TTM)
- $-2.26
- Dividend Yield
- —
Why Investors Own MDWD
- ✓High-growth profile — revenue up -5.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 65% gross margin and 8% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$14M▼ −3.6% YoY
Gross Margin (TTM)
65.2%▲ +2.9% YoY
Operating Income (TTM)
$5M▼ −3.6% YoY
Free Cash Flow (TTM)
$1M▼ −3.6% YoY
About MEDIWOUND LTD
A company profile for MEDIWOUND LTD isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
56/100
Analyst Price Target
ⓘAverage Target
$684.99
▲ +0.9% Upside
High Target$762.02
Low Target$627.13
Based on 39 analysts
Latest News & Updates
🚀
Bloomberg·2h ago
MEDIWOUND LTD tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Barron’s·5h ago
Analysts lift MDWD price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Barron’s·1d ago
MEDIWOUND LTD announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.